#USA #Orlando #ClinicalTrials #R&D #TransCelerate

TransCelerate BioPharma: Innovating the Future of R&D

TransCelerate BioPharma, a non-profit organization, has been at the forefront of transforming clinical research to enhance global health. With an unwavering commitment to improving the efficiency of clinical trials, its mission is to accelerate and simplify the journey from research to patient care.

At the upcoming SCOPE Summit 2025, scheduled for February 3-6 in Orlando, Florida, TransCelerate will engage healthcare professionals and stakeholders in detailed discussions about the future of drug development. Janice Chang, the CEO of TransCelerate, will present a keynote titled "Fast Forward to 2035: What Success Could Look Like in Converging Clinical Research and Care—And How to Get There". This presentation, featuring Mark McClellan, MD, PhD, promises to be a highlight, as it will delve into the critical topic of intersecting clinical research with patient care, setting a strategic vision for the years ahead.

The organization focuses not only on changing the landscape of research but also on cultivating collaborations among diverse stakeholders, including pharmaceutical companies, healthcare providers, and patients. Notable member companies, such as Amgen, Eli Lilly, and GSK, will play an integral role in the discussions planned during the summit, where topics like data sharing, risk-based quality management, and diversity in clinical trials will be thoroughly examined.

One of the key elements of TransCelerate's mission is to streamline clinical trials through shared resources and standardized processes. As envisioned in 2024, TransCelerate aims to bridge the gap between clinical care and research, creating a more efficient system that prioritizes patient-centric care.

Janice Chang states, "TransCelerate is more committed than ever to advancing clinical research globally by tackling systemic challenges and fostering collaboration across the ecosystem." This statement exemplifies the organization's approach to working alongside a variety of players in the healthcare field, leveraging collective efforts to foster progress.

Upcoming Sessions at SCOPE

TransCelerate will host a series of sessions at SCOPE, providing valuable insights into integral aspects of clinical research:

1. In Pursuit of Adoption: Risk-Based Quality Management and ICH E6 R3
- Date and Time: February 4, 11:30 AM EST
- Speakers: Vimi A. Shukkoor, Nicole Stansbury
- Overview: This session focuses on how to enhance the implementation of key guidelines outlined in ICH E6 R3 to ensure better quality management in clinical trials.

2. Data, Data Everywhere, and Not a Byte to Use
- Date and Time: February 4, 11:50 AM EST
- Moderator: Robert DiCicco
- Panelists: Chris Decker, Jesper Kjaer, Su Chen, Trevan Locke
- Overview: Addressing the potential of electronic health data to boost clinical outcomes and speed up regulatory decisions.

3. It's Been a While: 10 Years of Data Sharing and Reuse—Highs, Lows, and What's Next
- Date and Time: February 4, 3:45 PM EST
- Speaker: Medha Patel
- Overview: This session reflects on the progress made in data sharing over a decade and outlines future expectations.

Connecting at SCOPE 2025

Industry representatives and media who are interested in connecting with TransCelerate during the SCOPE conference are encouraged to reach out to schedule meetings with CEO Janice Chang and other leaders. Further information can be found on TransCelerate's official website.

About TransCelerate BioPharma

Founded with a mission to enhance global biopharmaceutical research and development, TransCelerate collaborates with its 20 member companies. By sharing best practices and resources, it hopes to accelerate the development of new treatments that are safe and effective for patients worldwide. The organization continues to innovate and evolve to meet the changing needs in healthcare research, ensuring a better future for countless patients.

For more information, please visit TransCelerate's website.